Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.13 USD | +2.86% | +1.16% | -26.83% |
Apr. 15 | Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating | MT |
Feb. 26 | Morgan Stanley Trims Veracyte's Price Target to $21 From $22, Keeps Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-26.83% | 1.54B | |
-18.88% | 11.03B | |
+53.75% | 3.5B | |
-32.50% | 2.23B | |
-14.31% | 2.16B | |
+28.55% | 1.12B | |
-3.28% | 737M | |
-23.50% | 477M | |
-43.27% | 411M | |
+17.30% | 342M |
- Stock Market
- Equities
- VCYT Stock
- News Veracyte, Inc.
- Goldman Sachs Cuts Veracyte Price Target to $28 From $32, Maintains Buy Rating